Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2200
Gene Symbol: FBN1
FBN1
0.500 Biomarker disease CTD_human Gene Expression Patterns Associated With Histopathology in Toxic Liver Fibrosis. 26396155 2016
Entrez Id: 210
Gene Symbol: ALAD
ALAD
0.500 Biomarker disease CTD_human Characterization of chemically induced liver injuries using gene co-expression modules. 25226513 2014
Entrez Id: 2200
Gene Symbol: FBN1
FBN1
0.500 Biomarker disease RGD Fibrillin-1 expression in normal and fibrotic rat liver and in cultured hepatic fibroblastic cells: modulation by mechanical stress and role in cell adhesion. 14661032 2004
Entrez Id: 210
Gene Symbol: ALAD
ALAD
0.500 Biomarker disease RGD Delta-Aminolevulinate synthase and delta-aminolevulinate dehydratase activities were determined in liver biopsy specimens obtained from 12 patients with hepatic cirrhosis. 6848403 1983
Entrez Id: 540
Gene Symbol: ATP7B
ATP7B
0.410 Biomarker disease BEFREE Experimental studies in mutant mice in which the copper-transporting ATPase gene (Atp7b) is disrupted revealed a drastic, time-dependent accumulation of hepatic copper that is accompanied by formation of regenerative nodes resembling cirrhosis. 25704483 2015
Entrez Id: 540
Gene Symbol: ATP7B
ATP7B
0.410 Biomarker disease CTD_human Wilson disease (WD) is caused by accumulation of excess copper (Cu) due to a mutation in the gene encoding the liver Cu transporter ATP7B, and is characterized by acute liver failure or cirrhosis and neuronal cell death. 25134866 2014
Entrez Id: 540
Gene Symbol: ATP7B
ATP7B
0.410 CausalMutation disease CLINVAR
Entrez Id: 5972
Gene Symbol: REN
REN
0.400 Biomarker disease BEFREE For instance, renin and prorenin bind their ubiquitous receptors, resulting in the local production of angiotensin (Ang) II; increased serum calcium and calcimimetic agents, through stimulation of extracellular calcium-sensing receptors (CaSR), blunt renin production and lead to natriuretic effects in human and experimental cirrhosis. 31580514 2020
Entrez Id: 3959
Gene Symbol: LGALS3BP
LGALS3BP
0.400 Biomarker disease BEFREE Serum Mac-2-binding protein glycosylation isomer at virological remission predicts hepatocellular carcinoma and death in chronic hepatitis B related cirrhosis. 31574141 2020
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.400 Biomarker disease BEFREE The levels of CD34/KDR-positive endothelial progenitor cells, CD133/KDR-positive endothelial progenitor cells, and vascular endothelial growth factor were higher in patients with cirrhosis ± hepatocellular carcinoma than in healthy controls (P = 0.017, P < 0.001 and P < 0.001, respectively). 31790004 2020
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE The factors independently associated with cirrhosis were albumin concentration [odds ratio (OR), 0.69; 95% confidence interval (CI), 0.58-0.83; <i>p</i> < .0001] and visceral fat accumulation (OR, 1.02; 95% CI, 1.01-1.04; <i>p</i> = .0003). 31564109 2020
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis. 31394283 2020
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.400 AlteredExpression disease BEFREE The current work was engrossed to weigh the potential role of Cichorium intybus linn against thioacetamide (TAA)-induced liver cirrhosis and their probable underlying biochemical and molecular mechanisms. farnesoid-X-receptor (FXR) expression, proliferating cell nuclear antigen (PCNA) immunoreactivity, and activated AMP protein kinase (pAMPK), sirtuin-1 (SIRT1), and interleukin-6 (IL6) levels were estimated in hepatic tissue by real-time PCR, immunohistochemistry, and immunoassay, respectively. 31368578 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE To assess the benefits and harms of any plasma volume expanders such as albumin, other colloids (polygeline, dextrans, hydroxyethyl starch solutions, fresh frozen plasma), intravenous infusion of ascitic fluid, crystalloids, or mannitol versus no plasma volume expander or versus another plasma volume expander for paracentesis in people with cirrhosis and large ascites. 31251387 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE In fact, patients with liver cirrhosis present posttranslational modifications on albumin that compromises its function. 29893696 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE Albumin infusion reduces the incidence of postparacentesis circulatory dysfunction among patients with cirrhosis and tense ascites compared with no treatment. 30312183 2019
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1
0.400 Biomarker disease BEFREE It seems that, unlike the TGF-β1 and SHH pathways, the YAP1 pathway does not play a significant role in the development of liver cirrhosis. 31087779 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites. 30230204 2019
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.400 Biomarker disease BEFREE The levels of CD34/KDR-positive endothelial progenitor cells, CD133/KDR-positive endothelial progenitor cells, and vascular endothelial growth factor were higher in patients with cirrhosis ± hepatocellular carcinoma than in healthy controls (P = 0.017, P < 0.001 and P < 0.001, respectively). 31490422 2019
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.400 Biomarker disease BEFREE To test the hypothesis that IL-6 is a suitable marker to identify patients with liver cirrhosis at high risk for the development of overt hepatic encephalopathy. 31583743 2019
Entrez Id: 5265
Gene Symbol: SERPINA1
SERPINA1
0.400 AlteredExpression disease BEFREE Its severe form is characterized by very low serum levels of AAT, and it most often affects the lungs (causing early-onset emphysema or chronic obstructive lung disease (COPD)) and/or liver (leading to jaundice and liver cirrhosis in children and adults). 30929319 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE Use of albumin therapy is recommended for management of disease complications in cirrhosis. 30700489 2019
Entrez Id: 5265
Gene Symbol: SERPINA1
SERPINA1
0.400 Biomarker disease BEFREE SERPINA1 Pi*Z was not associated with liver fibrosis or cirrhosis. 31517326 2019
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.400 Biomarker disease BEFREE A disintegrin-like and metalloproteinase with thrombospondin type-1 motifs 13 (ADAMTS13) and von Willebrand factor (VWF) are associated with the pathophysiology of liver cirrhosis and HCC through their roles in hypercoagulability; they are also associated with angiogenesis <i>via</i> vascular endothelial growth factor (VEGF). 31139312 2019
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1
0.400 Biomarker disease BEFREE To elucidate molecular mechanism underlying the suppressive role of miR-744 in LC, we observed that miR-744 and transforming growth factor β1 (TGFβ1) are inversely correlated in LC patients' sera as well as sera/livers from CCl<sub>4</sub>-induced LC mice. 31643031 2019